AACR (American Association for Cancer Research) Annual Meeting 2026

活動詳細資訊:

The AACR Annual Meeting is a leading global forum for cancer research, bringing together scientists, clinicians, and biotech leaders to share advances across basic, translational, and clinical oncology.

Novotech will be on site to connect with biotech sponsors and research partners working through the challenges of oncology drug development.

We welcome the opportunity to discuss how to move from early data to a clear clinical plan, and how to navigate key steps in development across different regions.

Meet with our oncology team for a focused discussion on your program, including:

• Turning early data into a practical clinical development plan
• Preparing for key regulatory steps, including IND pathways
• Designing oncology studies that support clear decision-making
• Feasibility and operational considerations for complex trials
• Regional differences across North America, Europe, and Asia-Pacific

Novotech has supported 800-plus oncology trials, including more than 200 solid tumor studies and over 60 breast cancer trials, giving sponsors practical insight into what it takes to move from early signals to a workable clinical path.

From first-in-human through to global studies, we work with biotech sponsors to navigate the practical challenges of oncology development and keep programs progressing.

Novotech Attendees:

• Dr. Steven Cha, Therapeutic Strategy Lead
• Sarah Anderson, Director, Therapeutic Strategy
• Deryck Middleton, Senior Business Development Manager
• Dr. Ann Lin, Business Development Director
• Rob Kent, Business Development Director

If you’ll be in San Diego, request a meeting via the form on this page.